Healthy volunteers test HIV/COVID drug's safety in early-stage trial
NCT ID NCT06991634
First seen Nov 17, 2025 · Last updated May 30, 2026 · Updated 20 times
Summary
This study looked at how azvudine tablets move through the body and whether they are safe in 24 healthy adults and older adults. Participants took a single dose, then after a break took daily doses for a week. The goal was to measure drug levels and check for side effects, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tianjin Fifth Central Hospital
Tianjin, Tianjin Municipality, China
Conditions
Explore the condition pages connected to this study.